doctitl gene therapi product issu public meet doctitl agenc agenc food drug administr hh agenc action action notic action summari summari food drug administr fda announc public meet discuss gene therapi product issu meet design obtain public testimoni biomed research academia biotechnolog associ government agenc individu organ relev inform concern gene vector product issu summari date date public meet held monday septemb 12 1994 6 p 7 30 p immedi follow nation institut health recombin dna advisori committe meet date address address public meet held nation institut health bldg 31c 9000 rockvil pike confer room 7 bethesda md registr requir address inform contact inform regard meet john g bishop center biolog evalu research hfm515 food drug administr 1401 rockvil pike rockvil md 208521448 3014021336 fax 3014967027 inform regard notic stephen ripley center biolog evalu research hfm635 food drug administr 1401 rockvil pike rockvil md 20852 1448 3015943074 supplem supplementari inform field gene therapi rapidli evolv new approach genet modif somat cell mitig human diseas develop ever increas number investig wish pursu gene therapi approach also increas number fda interest explor public industri mean overcom impedi develop use therapeut varieti human diseas without diminish patient safeti part process fda center biolog evalu research hold public meet discuss practic concern relat gene therapi vector product issu object meet 1 solicit public testimoni biomed research univers faculti member administr biotechnolog associ feder govern agenc individu organ relev inform concern gene vector product experi 2 solicit public testimoni particip concern potenti barrier gene therapi vector product develop innov mean overcom barrier 3 discuss qualiti control issu arisen gene therapi vector product 4 discuss current good manufactur practic good laboratori practic applic gene therapi vector product earliest phase investig new drug applic process manufactur licens product addit particip mention patient consum organ interest parti invit particip meet inform present meet consid fda develop futur point consid guidanc document date august 24 1994 supplem signer william k hubbard signer signjob interim deputi commission polici signjob frfile fr doc 9421469 file 82694 11 45 frfile bill bill code 416001f bill